Navigation Links
Eisai Donates More Than 80 Murals to Hospitals Around the United States
Date:11/11/2009

WOODCLIFF LAKE, N.J., Nov. 11 /PRNewswire/ -- Eisai Inc. today announced that it has donated more than 80 pieces of artwork, created by its employees, to hospitals across the United States.

The multi-panel murals were created by more than 1,200 of Eisai's field employees at a "PaintFest" team building event this summer. The event was conducted with the assistance of the Foundation for Hospital Art, which helps companies and organizations create artwork for donation to hospitals. The Foundation provided Eisai with canvasses with the painting templates, instructions and the assistance of professional artists to help participants - many of whom had never painted before - through the process.

Employee activities such as PaintFest fulfill a key tenet of Eisai's human health care mission, which is to give first thought to patients and their families and to increasing the benefits that healthcare provides. Such activities enable employees to connect with the needs of patients and families in an impactful way.

"This was an amazing experience for all at Eisai who participated in PaintFest," said Cynthia Schwalm, President, U.S. Pharmaceuticals, Eisai Inc. "It served as a reminder to each of us what patients and their families go through when they are facing a health issue that has put them in a hospital setting. That something as seemingly simple as a piece of art can really help to alleviate pain, discomfort or anxiety impresses upon us what patients and their families go through, and reminds us how important it is for us to do all we can to help improve the lives of patients and their families."

The Foundation for Hospital Art (www.hospitalart.org) has worked with various volunteers and partners to donate more than 35,000 paintings to more than 2,000 hospitals worldwide since the organization was founded in 1984.

"We were thrilled for the opportunity to work with Eisai in our continued effort to offer comfort to hospital patients," said John Feight, founder and Executive Director of The Foundation for Hospital Art. "It is especially rewarding to work with partners like Eisai, who truly understand the needs of patients and their families, and are dedicated to actively seeking ways to improve the their lives."

Eisai is proud to have the artwork created by its employees on display at a variety of hospitals around the country, including the following:

         Children's Hospital (New Orleans, Louisiana)
         Children's Hospital of Philadelphia (Philadelphia, Pennsylvania)
         Children's Hospital of Pittsburgh of UPMC (Pittsburgh, Pennsylvania)
         Hoboken University Medical Center (Hoboken, New Jersey)
         Kosair Children's Hospital (Louisville, Kentucky)
         Methodist Children's Hospital (San Antonio, Texas)
         Miami Children's Hospital (Miami, Florida)
         Texas Children's Hospital (Houston, Texas)

In addition, Eisai is pleased to have their artwork on display at the Paramus and Ridgewood facilities of the New Jersey nonprofit agency Children's Aid and Family Services.

About Eisai Inc.

Eisai Inc. is a wholly-owned subsidiary of Eisai Corporation of North America. Established in 1995 and ranked among the top-20 U.S. pharmaceutical companies (based on retail sales), the company began marketing its first product in the United States in 1997 and has rapidly grown to become a fully integrated pharmaceutical business with fiscal year 2008 (year ended March 31, 2009) sales of approximately $3.7 billion. Eisai Inc.'s areas of commercial focus include neurology, gastrointestinal disorders and oncology/critical care. The company serves as the U.S. pharmaceutical operation of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Headquartered in Woodcliff Lake, New Jersey, Eisai Inc. has several R&D facilities in Massachusetts, New Jersey and North Carolina, as well as manufacturing facilities in Maryland and North Carolina. For more information about Eisai, please visit www.eisai.com.

SOURCE Eisai Inc.


'/>"/>
SOURCE Eisai Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Morphotek(R), Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer
2. Teikoku Pharma USA and Eisai Co., Ltd. Announce Licensing Agreement for a New 7-Day Transdermal Formulation of Donepezil.
3. Eisai and Bial Announce Partnership Agreement for the European Commercialisation of the Novel Once Daily Anti-Epileptic Zebinix(R)
4. Eisai Inc. and the North American Thrombosis Forum (NATF)* Introduce the DVTeamCare(TM) Hospital Award and Call for Nominations
5. Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes
6. Biologic Drugs, Particularly Centocor/Janssen-Cilags Stelara and Abbott/Eisais Humira, will Drive the Psoriasis Drug Market to $5 Billion by 2017
7. Eisai Inc. Supports Acting Surgeon Generals Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism
8. Eisai Renews Its Commitment to Responsible Healthcare Community Interactions in Accordance with the Revised PhRMA Marketing Code
9. Eisai Inc. and the Alzheimers Association Introduce the C.A.R.E. Pharmacy Award and Call for Nominations
10. Eisai Corporation of North America Announces Appointment of Vice President of U.S. Corporate Communications
11. Sutter Health Donates $255,000 to Help the Hungry This Holiday Season
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
(Date:10/12/2017)... ... 12, 2017 , ... Dr. Parsa Mohebi, the Los Angeles ... to the newly revamped Cosmetic Town journal section, featuring articles written ... known as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and ... 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness will ... Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ... LLC , and named its founder as Diplomat,s chief ... Tennessee , will operate under Diplomat subsidiary ... offerings for health care partners to include IT outsourcing, ... "In an interoperable world, technology delivers comprehensive insight ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
Breaking Medicine Technology: